COMP <GO>
NKTR vs OPK // 10Y YIELD & FRED MACRO BETA
Nektar Therapeutics (NASDAQ) VS. OPKO Health Inc. (NASDAQ) • 15-METRIC TALLY: NKTR 1
— OPK 7
■ METRIC PARITY
LAST: $37.76 (+2.19%) • MKT CAP: $1.26B
macro-sensitivity
—
LAST: $1.72 (0.00%) • MKT CAP: $1.28B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NKTR VS. OPK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NKTR | OPK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 33.90% | +62.10 | NKTR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -10.20% | -24.80 | OPK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.60% | -14.41% | -1.19 | OPK | /fcf-yield <GO> |
| Operating Margin | -60.00% | -19.30% | -40.70 | OPK | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -43.90% | -14.90% | -29.00 | OPK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | OPK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.3 | 64.0 | -32.70 | OPK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $1.28B | -$22.1M | OPK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NKTR REV | OPK REV | NKTR GROSS % | OPK GROSS % | NKTR FCF | OPK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $55.2M | $606.9M | 98.0% | 33.9% | -$208.7M | -$178.5M |
| FY 2024 | $98.4M | $713.1M | 68.8% | 30.6% | -$177.2M | -$183.5M |
| FY 2023 | $90.1M | $863.5M | — | — | -$192.6M | -$28.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NKTR // BETA —
OPK // BETA —